Newsroom
August 11, 2020
Dr. Tom Patterson, Infectious Diseases, was interviewed about the drug remdesivir now entering the third phase of clinical trials at University Hospital, keeping us on the cutting edge of the battle against COVID-19. In this Adaptive COVID-19 Treatment Trial 3, sponsored by the National Institutes of Health, remdesivir will be paired with a drug called […]
August 11, 2020
Dr. Tom Patterson, Infectious Diseases, was interviewed about the drug remdesivir now entering the third phase of clinical trials at University Hospital, keeping us on the cutting edge of the battle against COVID-19. In this Adaptive COVID-19 Treatment Trial 3, sponsored by the National Institutes of Health, remdesivir will be paired with a drug called […]
August 11, 2020
Dr. Tom Patterson, Infectious Diseases, was interviewed about the drug remdesivir now entering the third phase of clinical trials at University Hospital, keeping us on the cutting edge of the battle against COVID-19. In this Adaptive COVID-19 Treatment Trial 3, sponsored by the National Institutes of Health, remdesivir will be paired with a drug called […]
August 11, 2020
Dr. Anoop Nambiar, Pulmonology, warned of the long-term health effects of COVID-19 on its survivors; he indicated that there’s a 20 percent chance anyone with COVID-19 could be hospitalized and a five to ten percent chance that patient could end up in critical care Read and watch the story.
August 11, 2020
Dr. Steven Pliszka, Psychiatry and Behavioral Sciences, explained the dangers of too much social media time, that has occurred as a result of social distancing, and urged taking breaks from the screen, no matter how hard it may be. Read and watch the story.
August 11, 2020
Dr. Steven Pliszka, Psychiatry and Behavioral Sciences, explained the dangers of too much social media time, that has occurred as a result of social distancing, and urged taking breaks from the screen, no matter how hard it may be. Read and watch the story.